Phase III General Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

August 31, 2009

Conditions
Stomach Diseases
Interventions
DRUG

NPO-11

20 mL NPO-11

Trial Locations (4)

Unknown

Chūbu

Kansai

Kanto

Shikoku

Sponsors
All Listed Sponsors
lead

Nihon Pharmaceutical Co., Ltd

INDUSTRY

NCT00745459 - Phase III General Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy | Biotech Hunter | Biotech Hunter